Literature DB >> 22110292

Infections in hemodialysis: a concise review. Part II: blood transmitted viral infections.

T Eleftheriadis1, V Liakopoulos, K Leivaditis, G Antoniadi, I Stefanidis.   

Abstract

Hemodialysis (HD) patients are particularly predisposed to infections. It seems that the HD procedure per se as well as disturbances in both innate and adaptive immunity significantly contribute to this susceptibility. Infections are the major cause of morbidity and the second cause of death following cardiovascular events in HD patients. Episodes of bacteremia and pneumonia account for the majority of severe infections in this population. In addition to these bacterial infections another common problem in HD units is the blood transmitted viral infections, particularly infections caused by hepatitis B virus, hepatitis C virus and Human immunodeficiency virus. A number of safety concerns exist for limiting the spread of these viral infections among HD patients and the staff of the unit. The aim of the present review is to present in a concise albeit practical form the difficult aspect of infections in HD. For practical reasons the review is separated in two parts. The previous first part covered bacteremia and respiratory infections, while the present second part covers blood transmitted viral infections.

Entities:  

Keywords:  hemodialysis; hepatitis B virus; hepatitis C virus; human immunodeficiency virus; infection; review

Year:  2011        PMID: 22110292      PMCID: PMC3209673     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  112 in total

1.  Host responses to hepatitis B infection in patients in a chronic hemodialysis unit.

Authors:  W T London; J S Drew; E D Lustbader; B G Werner; B S Blumberg
Journal:  Kidney Int       Date:  1977-07       Impact factor: 10.612

2.  Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA.

Authors:  E Tanaka; C Ohue; K Aoyagi; K Yamaguchi; S Yagi; K Kiyosawa; H J Alter
Journal:  Hepatology       Date:  2000-08       Impact factor: 17.425

3.  Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation.

Authors:  Tadeusz-Wojciech Lapinski; Robert Flisiak; Jerzy Jaroszewicz; Malgorzata Michalewicz; Oksana Kowalczuk
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

4.  Histopathological impacts of hepatitis virus infection in hemodialysis patients: should liver biopsy be performed before renal transplantation?

Authors:  M Ozdoğan; O Ozgür; G Gür; S Boyacioğlu; Y Ozderin; B Demirhan; H Telatar; M Haberal
Journal:  Artif Organs       Date:  1997-05       Impact factor: 3.094

5.  Antiretroviral drug dosing errors in HIV-infected patients undergoing hemodialysis.

Authors:  Jérôme Tourret; Isabelle Tostivint; Sophie Tézenas Du Montcel; Svetlana Karie; Vincent Launay-Vacher; Cécile Vigneau; Christel Bessette; Gilbert Deray; Corinne Isnard Bagnis
Journal:  Clin Infect Dis       Date:  2007-08-16       Impact factor: 9.079

6.  Evolution of naturally acquired hepatitis B immunity in the long-term hemodialysis population.

Authors:  Andre F Charest; Anne Grand'Maison; James McDougall; Marc B Goldstein
Journal:  Am J Kidney Dis       Date:  2003-12       Impact factor: 8.860

7.  Racial differences in end-stage renal disease rates in HIV infection versus diabetes.

Authors:  Andy I Choi; Rudolph A Rodriguez; Peter Bacchetti; Daniel Bertenthal; Paul A Volberding; Ann M O'Hare
Journal:  J Am Soc Nephrol       Date:  2007-10-17       Impact factor: 10.121

8.  Chronic inflammation and CD16+ natural killer cell zeta-chain downregulation in hemodialysis patients.

Authors:  Theodoros Eleftheriadis; Charalambos Kartsios; Efi Yiannaki; Polizo Kazila; Georgia Antoniadi; Vassilios Liakopoulos; Dimitra Markala
Journal:  Blood Purif       Date:  2008-05-08       Impact factor: 2.614

9.  Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease.

Authors:  Andy I Choi; Rudolph A Rodriguez; Peter Bacchetti; Paul A Volberding; Diane Havlir; Daniel Bertenthal; Alan Bostrom; Ann M O'Hare
Journal:  Clin Infect Dis       Date:  2007-12-15       Impact factor: 9.079

10.  Outcome and prognosis factors in HIV-infected hemodialysis patients.

Authors:  Jérôme Tourret; Isabelle Tostivint; Sophie Tézenas du Montcel; Jennifer Bragg-Gresham; Svétlana Karie; Cécile Vigneau; Jean-Baptiste Guiard-Schmid; Gilbert Deray; Corinne Isnard Bagnis
Journal:  Clin J Am Soc Nephrol       Date:  2006-09-20       Impact factor: 8.237

View more
  14 in total

Review 1.  Immune response to hepatitis B vaccine among patients on hemodialysis.

Authors:  Gasim I Gasim; Abdelhaleem Bella; Ishag Adam
Journal:  World J Hepatol       Date:  2015-02-27

2.  Natural evolution of hepatitis C virus infection in hemodialysis Tunisian patients and CTLA-4 SNP's.

Authors:  Leila Ksiaa Cheikhrouhou; Yousr Lakhoua-Gorgi; Imen Sfar; Salwa Jendoubi-Ayed; Houda Aouadi; Mouna Makhlouf; Khaled Ayed; Taieb Ben Abdallah
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

Review 3.  Factors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patients.

Authors:  Theodoros Eleftheriadis; Georgios Pissas; Georgia Antoniadi; Vassilios Liakopoulos; Ioannis Stefanidis
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

4.  Damage-associated molecular patterns derived from mitochondria may contribute to the hemodialysis-associated inflammation.

Authors:  Theodoros Eleftheriadis; Georgios Pissas; Georgia Antoniadi; Vassilios Liakopoulos; Ioannis Stefanidis
Journal:  Int Urol Nephrol       Date:  2013-03-21       Impact factor: 2.370

5. 

Authors:  Nestor Toapanta; Zaira Castañeda; José Zúñiga; Juan León-Román; Natalia Ramos; María Azancot; María José Soler
Journal:  Nefrologia (Engl Ed)       Date:  2021-05-27

6.  Controversial report regarding seroprevalence of hepatitis B and C viruses among hemodialysis patients in kerman province, South-East iran.

Authors:  Mojgan Noroozi Karimabad; Gholamhossein Hassanshahi; Mohammad Kazemi Arababadi
Journal:  Hepat Mon       Date:  2013-03-13       Impact factor: 0.660

7.  Serological investigation for hepatitis E virus infection in the patients with chronic maintenance hemodialysis from southwest of Iran.

Authors:  Omid R Zekavat; Alireza Makarem; Mohammad Y Karami; Aida Amanat; Maesoomeh Mohandes; Mojtaba Habibagahi
Journal:  Asian J Transfus Sci       Date:  2013-01

8.  Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses among haemodialysis patients in two newly opened centres in Cameroon.

Authors:  Henry Namme Luma; Marie Patrice Halle; Servais Albert Fiacre Bagnaka Eloumou; Fondong Azingala; Felicite Kamdem; Olivier Donfack-Sontsa; Gloria Ashuntantang
Journal:  Pan Afr Med J       Date:  2017-07-31

9.  Torque Teno Virus (TTV) Among β-Thalassemia and Haemodialysis Patients in Mazandaran Province (North of Iran).

Authors:  Hossein Jalali; Mohammad Reza Mahdavi; Najmeh Zaeromali
Journal:  Int J Mol Cell Med       Date:  2017-02-28

10.  Hemodialysis-related changes in phenotypical features of monocytes.

Authors:  Vassilios Liakopoulos; Andreas Jeron; Aneri Shah; Dunja Bruder; Peter R Mertens; Xenia Gorny
Journal:  Sci Rep       Date:  2018-09-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.